The Vanguard Group 13D and 13G filings for BioMarin Pharmaceutical Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-10 1:14 pm Purchase |
2024-06-28 | 13G | BioMarin Pharmaceutical Inc. BMRN |
The Vanguard Group | 18,992,533 10.000% |
943,976 (+5.23%) |
Filing |
| 2024-02-13 5:01 pm Purchase |
2023-12-29 | 13G | BioMarin Pharmaceutical Inc. BMRN |
The Vanguard Group | 18,048,557 9.580% |
683,477 (+3.94%) |
Filing |
| 2023-02-09 11:12 am Purchase |
2022-12-30 | 13G | BioMarin Pharmaceutical Inc. BMRN |
The Vanguard Group | 17,365,080 9.340% |
1,014,049 (+6.20%) |
Filing |
| 2022-02-09 3:33 pm Sale |
2021-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN |
The Vanguard Group | 16,351,031 8.910% |
-18,658 (-0.11%) |
Filing |
| 2021-02-10 10:39 am Sale |
2020-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN |
The Vanguard Group | 16,369,689 9.020% |
-167,091 (-1.01%) |
Filing |